PAPZIMEOS 500000000000 {VP}/mL
zopapogene imadenovec · INJECTION, SUSPENSION · Precigen, Inc.
PAPZIMEOS is a injection, suspension containing zopapogene imadenovec at 500000000000 {VP}/mL, taken subcutaneous. Manufactured by Precigen, Inc..
Key Facts
- Brand Name
- PAPZIMEOS
- Generic Name
- zopapogene imadenovec
- NDC Code (Product)
84768-511- Manufacturer
- Precigen, Inc.
- Strength
- 500000000000 {VP}/mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125832
- Marketing Start
- 09/15/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is PAPZIMEOS used for?
PAPZIMEOS contains zopapogene imadenovec. It is a injection, suspension taken subcutaneous. Consult your doctor for specific uses.
Is PAPZIMEOS a controlled substance?
PAPZIMEOS is not classified as a controlled substance by the DEA.
What is the generic name for PAPZIMEOS?
The generic name for PAPZIMEOS is zopapogene imadenovec. There are no other listed brand versions of zopapogene imadenovec.
What is the NDC code for PAPZIMEOS 500000000000 {VP}/mL?
The NDC (National Drug Code) for PAPZIMEOS 500000000000 {VP}/mL is 84768-511, listed by Precigen, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)